Literature DB >> 22289527

Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression.

Y J Geng1, S L Xie, Q Li, J Ma, G Y Wang.   

Abstract

Increasing evidence suggests that large intervening non-coding RNAs (lincRNAs) regulate key pathways in cancer invasion and metastasis. In this observational retrospective study, the expression of the oncogenic lincRNA HOX transcript antisense RNA (HOTAIR) gene was measured in 63 patients with hepatocellular carcinoma (HCC) following hepatic resection. The HOTAIR gene was significantly overexpressed in HCC tissues compared with adjacent non-tumour tissues. Patients with high HOTAIR gene expression in their tumours had an increased risk of recurrence after hepatectomy. There was also a significant correlation between HOTAIR expression and lymph node metastasis. In vitro assays in the HCC cell line Bel7402 demonstrated that knockdown of HOTAIR lincRNA reduced cell proliferation and was associated with reductions in levels of matrix metalloproteinase-9 and vascular endothelial growth factor protein, which are important for cell motility and metastasis. In conclusion, HOTAIR lincRNA might be a potential biomarker for the existence of lymph node metastasis in HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22289527     DOI: 10.1177/147323001103900608

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  186 in total

1.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma.

Authors:  Youtao Xu; Jie Wang; Mantang Qiu; Lei Xu; Ming Li; Feng Jiang; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2014-10-31

2.  lincRNA HOTAIR as a novel promoter of cancer progression.

Authors:  Gregory Loewen; Ying Zhuo; Yan Zhuang; Janarthanan Jayawickramarajah; Bin Shan
Journal:  J Can Res Updates       Date:  2014-07

Review 3.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 4.  Long non-coding RNA HOTAIR in carcinogenesis and metastasis.

Authors:  Jinsong Zhang; Peijing Zhang; Li Wang; Hai-long Piao; Li Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-10-27       Impact factor: 3.848

5.  HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma.

Authors:  Jun-Xia Zhang; Lei Han; Zhao-Shi Bao; Ying-Yi Wang; Lu-Yue Chen; Wei Yan; Shi-Zhu Yu; Pei-Yu Pu; Ning Liu; Yong-Ping You; Tao Jiang; Chun-Sheng Kang
Journal:  Neuro Oncol       Date:  2013-11-07       Impact factor: 12.300

6.  Long non-coding RNAs and hepatocellular carcinoma.

Authors:  Fu-Jun Yu; Jian-Jian Zheng; Pei-Hong Dong; Xiao-Ming Fan
Journal:  Mol Clin Oncol       Date:  2014-09-25

7.  Quantitative Proteomics Analysis Reveals Novel Insights into Mechanisms of Action of Long Noncoding RNA Hox Transcript Antisense Intergenic RNA (HOTAIR) in HeLa Cells.

Authors:  Peng Zheng; Qian Xiong; Ying Wu; Ying Chen; Zhuo Chen; Joy Fleming; Ding Gao; Lijun Bi; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2015-03-11       Impact factor: 5.911

Review 8.  An emerging understanding of long noncoding RNAs in kidney cancer.

Authors:  Shuigen Zhou; Jiandong Wang; Zhengyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

9.  Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.

Authors:  Jun Lv; Ling Ma; Xi-Lin Chen; Xiao-Hui Huang; Qian Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

10.  A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.

Authors:  Süleyman Bayram; Ahmet Taner Sümbül; Erdoğan Dadaş
Journal:  Tumour Biol       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.